Summary of the MHRA Good Distribution Practice Symposium 2023
Register now for ECA's GMP Newsletter
Just recently, you could read about the Good Manufacturing and Distribution Practice Symposia 2023, organized by the Medicines and Healthcare products Regulatory Agency (MHRA) on 21 and 22 February 2023. The first day of the conference focused on regulatory developments in the area of Good Distribution Practice (GDP).
A summary of the GDP part was now published on the MHRA Inspectorate blog. The article dated 02 May 2023 was written by Manuela Krasteva. In the introduction, she states that "the event included a variety of topics with a special emphasis on updates on our regulatory position and the MHRA’s role as a sovereign regulator. The theme of the day was largely influenced by the changes following the UK’s departure from the EU."
The blog post goes on, giving a brief summary of the individual contributions. Among the topics presented were the environmental changes and their impact on GDP activities, as well as the role of the so-called Responsible Person (Import), RPi.
To read the full article, please see the MHRA Inspectorate blog "MHRA Good Distribution Practice Symposium 2023".
Related GMP News
16.01.2025EMA adds Considerations for Wholesale Distributors and Brokers on suspicious Offers
16.01.2025Swissmed informs about Control Campaign against illegal Trading in Medicinal Products
16.01.2025Two new PICS Documents on Remote Assessments published
16.01.2025The GDP Non-Compliance Reports of 2024 - An Overview
17.12.2024GDP in the US: Pre-posting of USP Chapter <1079.2> on MKT
17.12.2024Romanian Authority Issues further GDP Non-Compliance Report